{
  "docId": "019dd923-622c-750b-8b9a-21918ac10c17",
  "docSlug": "f3db2294dcf9",
  "documentTitle": "Harmony Biosciences (HRMY)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2023-03-28 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 12,
  "pageCount": 366,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses a highly critical, investigative tone, framing the subject as a 'scam' and a 'failed launch'.",
  "elementsJson": [
    "headline_text",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-21918ac10c17/12",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17#slide-12",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The trials are a poster child for the weaknesses and loopholes in the FDA's fast-track approval process, where it appears that anything suffices for evidence in the case of a rare condition.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64d0-7099-9cc9-131fc102df86",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.85,
        "x": 0.07,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "We conducted interviews with 16 current and former prescribers of Wakix... We summarize the main findings: there are almost no high volume prescribers except paid speakers; supernormal patient discontinuation rate of 30-100%...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "82588aa0-da42-4713-8deb-33a0c94b48ef",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.85,
        "x": 0.07,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "Part 3. The foreign clinical trials that led to FDA approval were a scam, a poster child for the loopholes and abuses in the expedited approval pathway, reminiscent of the recent Aduhelm controversy.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "89a85dfc-7b67-4568-94c6-9a1b1fbc77df",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.5,
        "x": 0.07,
        "y": 0.24
      },
      "kind": "paragraph",
      "text": "The foreign clinical trials that led to FDA approval lack credibility",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a8e1af10-e9fb-4498-a9ee-16affc8b31ff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.85,
        "x": 0.07,
        "y": 0.61
      },
      "kind": "paragraph",
      "text": "Physician interviews indicate a failed launch; an ineffective product with high discontinuation rates, and no more growth",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b791f442-44cc-4d69-b928-f26ef4617ed1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.07,
        "y": 0.27
      },
      "kind": "paragraph",
      "text": "The trials are a poster child for the weaknesses and loopholes in the FDA's fast-track approval process... Harmony's clinical trials indicate a pattern of cherry-picking 'successful' trials and burying the ones that undermine the drug.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bda47dd5-4873-443f-a4f1-4fb4478ea788",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.85,
        "x": 0.07,
        "y": 0.49
      },
      "kind": "paragraph",
      "text": "Part 4. The most devastating physician commentary we have ever heard, even from Harmony's speakers, medical advisors, and highest volume prescribers, based on 16 in-depth interviews.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ece6d71b-44c1-402d-9acf-4141b6ed402e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "Executive summary (cont'd)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4aa36b3a-46ea-4846-b01e-d1177995be80",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "9523b902-6236-4d34-bc60-dd5b72b43edf",
      "evidence": "paragraph/paragraph: The trials are a poster child for the weaknesses and loopholes in the FDA's fast-track approval process...",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 30,
      "from": 11,
      "beatId": "d0905c6f-1d0c-46ed-96fd-5548f20fae57",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Monster",
      "beatSlug": null,
      "evidence": "The document presents the 'monster' of the company's troubled drug and financial reporting",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}